
Guido Papa and Anna Albecka-Moreau in the James lab contribute to University of Cambridge study, finding that Delta variant spike protein induces higher cell-cell fusion and is less sensitive to inhibition by neutralising antibodies present in vaccinated individuals than the original SARS-CoV-2 strain. More…